| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 8,945,372 | $894,537,233.00 | 8.19% |
| U.S. Treasury 3.625% 9/30/2030 | Fixed Income | 257,124,000 | $255,828,326.00 | 2.34% |
| U.S. Treasury 4.25% 8/15/2035 | Fixed Income | 197,693,000 | $199,283,816.00 | 1.82% |
| U.S. Treasury 4.875% 8/15/2045 | Fixed Income | 84,130,000 | $85,996,643.00 | 0.79% |
| Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 77,669,000 | $79,677,287.00 | 0.73% |
| Bristol-Myers Squibb Co. 5.20% 2/22/2034 | Fixed Income | 76,118,000 | $78,963,062.00 | 0.72% |
| Cisco Systems, Inc. 5.05% 2/26/2034 | Fixed Income | 69,323,000 | $71,735,718.00 | 0.66% |
| New Economy Assets Phase 1 Issuer, LLC, Series 2021-1, Class A1, 1.91% 10/20/2061 | Fixed Income | 85,298,000 | $71,432,640.00 | 0.65% |
| Takeda U.S. Financing, Inc. 5.20% 7/7/2035 | Fixed Income | 69,251,000 | $70,417,810.00 | 0.64% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 66,997,000 | $68,964,568.00 | 0.63% |
| Oracle Corp. 5.50% 8/3/2035 | Fixed Income | 64,456,000 | $66,355,003.00 | 0.61% |
| U.S. Treasury 3.375% 9/15/2028 | Fixed Income | 65,242,700 | $64,796,707.00 | 0.59% |
| Pfizer Investment Enterprises Pte., Ltd. 5.30% 5/19/2053 | Fixed Income | 65,138,000 | $62,993,201.00 | 0.58% |
| Marsh & McLennan Cos., Inc. 5.00% 3/15/2035 | Fixed Income | 59,277,000 | $60,036,457.00 | 0.55% |
| Pacific Gas and Electric Co. 2.50% 2/1/2031 | Fixed Income | 66,668,000 | $59,422,655.00 | 0.54% |